Nazarbayev University

  • Kazakhstan

  • Kazakhstan

Research Output

Filter
Letter
Letter

A case of severe dermatomyositis in an African woman

Ocampo, C., Segwagwe, M. L., Deonarain, J., Cainelli, F. & Vento, S., May 2014, In : Israel Medical Association Journal. 16, 5, p. 329-330 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection [3]

Nobili, V., Vento, S., Dionisi, C., Sartorelli, M. R., Russo, C. & Marcellini, M., Jan 2006, In : Journal of Gastroenterology and Hepatology (Australia). 21, 1 PART2, 1 p.

Research output: Contribution to journalLetter

3 Citations (Scopus)

Acute opisthorchiasis in a Kazakh man

Atygaeva, S., Cainelli, F. & Vento, S., Jun 1 2018, In : Israel Medical Association Journal. 20, 6, p. 395-396 2 p.

Research output: Contribution to journalLetter

Adherence to HAART in HIV [3]

Lazzarini, L., Lanzafame, M., Trevenzoli, M., Vento, S. & Concia, E., Mar 6 1999, In : Lancet. 353, 9155, 1 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

Allopurinol provides long-term protection for experimentally induced testicular torsion in a rabbit model [5]

Kehinde, E. O., Nov 2005, In : BJU International. 96, 7, p. 1147-1148 2 p.

Research output: Contribution to journalLetter

A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients

Lanzafame, M., Lattuada, E., Rigo, F. & Vento, S., Jun 1 2013, In : Journal of Acquired Immune Deficiency Syndromes. 63, 2, p. e81-e82

Research output: Contribution to journalLetter

3 Citations (Scopus)

ANTI-PRE-S2 ANTIBODIES IN CLEARANCE OF HEPATITIS B VIRUS

Vento, S., Zanetti, A. R., Tanzi, E., Colombo, M. & Mannucci, P. M., Aug 20 1988, In : The Lancet. 332, 8608, p. 447-448 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Antiretroviral therapy-associated diseases are common in the long-term

Lanzafame, M., Lattuada, E., Zoppini, G. & Vento, S., Sep 1 2011, In : AIDS Research and Human Retroviruses. 27, 9, p. 931-932 2 p.

Research output: Contribution to journalLetter

Antiretroviral therapy in low-resource settings

Cainelli, F., Lanzafame, M. & Vento, S., Oct 23 2010, In : The Lancet. 376, 9750, 1 p.

Research output: Contribution to journalLetter

A rare case of a hydatid cyst of the neck in a Kazakh boy

Suleimenova, A., Utebaliyev, R., Jenalayev, D., Bilal, R., Isabekova, A. & Vento, S., Sep 1 2017, In : Israel Medical Association Journal. 19, 9, p. 584-585 2 p.

Research output: Contribution to journalLetter

A Rare Case of Nasal NK/T-Cell Lymphoma in a Kazakh Man

Goremykina, M., Gerdt, A., Ibraev, Y., Kalmakbayev, B., Dyakonov, K., Skinder, O. & Vento, S., Dec 1 2018, In : The Israel Medical Association journal : IMAJ. 20, 12, p. 790-791 2 p.

Research output: Contribution to journalLetter

A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients

Lanzafame, M., Bonora, S., Lattuada, E., Calcagno, A. & Vento, S., Sep 1 2011, In : Brazilian Journal of Infectious Diseases. 15, 5, p. 498-500 3 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection [2]

Nobili, V., Vento, S., Comparcola, D., Sartorelli, M. R., Luciani, M. & Marcellini, M., Feb 1 2004, In : Pediatric Infectious Disease Journal. 23, 2 SUPPL., p. 184-185 2 p.

Research output: Contribution to journalLetter

13 Citations (Scopus)

Basophils activated via TLR signaling may contribute to pathophysiology of type I autoimmune pancreatitis”

Poddighe, D., Brambilla, I. & Marseglia, G. L., Jun 1 2018, In : Journal of Gastroenterology. 53, 6, p. 791-792 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

BCG efficacy and tuberculin skin testing [2]

Cainelli, F. & Vento, S., Apr 27 2002, In : Lancet. 359, 9316, p. 1521-1522 2 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

Blood-borne viruses and health care workers [3]

Ciuffa, V., Fazio Tirrozzo, S. & Vento, S., Oct 14 2002, In : Archives of Internal Medicine. 162, 18, p. 2141-2142 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Can antiretroviral therapy be safely interrupted and, if so, when?

Lattuada, E., Lanzafame, M. & Vento, S., Feb 1 2011, In : HIV Medicine. 12, 2, p. 126-127 2 p.

Research output: Contribution to journalLetter

Cancer control in Africa: Which priorities?

Vento, S., Apr 1 2013, In : The Lancet Oncology. 14, 4, p. 277-279 3 p.

Research output: Contribution to journalLetter

17 Citations (Scopus)

Can HIV-1 viral interference be used therapeutically?

Vento, S. & Cainelli, F., Jan 1 2013, In : The Lancet Infectious Diseases. 13, 1, p. 9-10 2 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

Can neurointensive care units decrease mortality rate and improve outcome of neurocritically ill patients in developing countries?

Viderman, D., Bilotta, F., Umbetzhanov, Y. & Zhumadilov, A., Jun 1 2019, In : Trends in Anaesthesia and Critical Care. 26-27, p. 19-21 3 p.

Research output: Contribution to journalLetter

Can we really identify HIV-1 long-term nonprogressors? [2]

Vento, S., Lanzafame, M., Malena, M., Tositti, G., Cainelli, F., Concia, E. & Masiero, G., Sep 1 2004, In : Journal of Acquired Immune Deficiency Syndromes. 37, SUPPL. 1, p. 1218-1219 2 p.

Research output: Contribution to journalLetter

4 Citations (Scopus)

Cell line standards to reduce HER-2/neu assay variation and the potential of automated image analysis to provide more accurate cut points for predicting clinical response to trastuzumab (multiple letters)

Jasani, B., Miller, K., Rhodes, A., Sykes, R., Al-Sam, S. & Paradiso, A., Feb 1 2005, In : American Journal of Clinical Pathology. 123, 2, p. 314-315 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Cerebral palsy: a multidisciplinary, integrated approach is essential

Bulekbayeva, S., Daribayev, Z., Ospanova, S. & Vento, S., Apr 1 2017, In : The Lancet Global Health. 5, 4, p. e401

Research output: Contribution to journalLetter

3 Citations (Scopus)

Cervical cancer vaccine: The Indian sub-continental context

Rai, M. A. & Ali, S. H., Nov 30 2006, In : Vaccine. 24, 49-50, 1 p.

Research output: Contribution to journalLetter

Childhood hepatitis C virus infection [3]

Comparcola, D., Nobili, V., Sartorelli, M. R., Marcellini, M., Cainelli, F. & Vento, S., Dec 2005, In : Journal of Gastroenterology and Hepatology (Australia). 20, 12, p. 1948-1949 2 p.

Research output: Contribution to journalLetter

Childhood infections and autoimmune diseases [4] (multiple letters)

Vento, S., Cainelli, F., Lemke, H., Lange, H. & Zinkernagel, R. M., May 30 2002, In : New England Journal of Medicine. 346, 22, p. 1749-1750 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

CLINICAL REACTIVATION OF HEPATITIS B IN ANTI-HBs-POSITIVE PATIENTS WITH AIDS

Vento, S., Di Perri, G., Luzzati, R., Cruciani, M., Garofano, T., Mengoli, C., Concia, E. & Bassetti, D., Feb 11 1989, In : The Lancet. 333, 8633, p. 332-333 2 p.

Research output: Contribution to journalLetter

82 Citations (Scopus)

Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS [1]

Bonora, S., Lanzafame, M., Allegranzi, B., Soldani, F., Vento, S., Cazzadori, A., Di Perri, G. & Concia, E., Jan 1 1997, In : Journal of Infection. 35, 2, 1 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium

Brusic, V., Gottardo, R., Kleinstein, S. H., Davis, M. M., Hafler, D. A., Quill, H., Palucka, A. K., Poland, G. A., Pulendran, B., Reinherz, E. L., Stuart, K. D. & Togias, A., Feb 1 2014, In : Nature Biotechnology. 32, 2, p. 146-148 3 p.

Research output: Contribution to journalLetter

44 Citations (Scopus)

Concentrated epidemics of HIV, HCV, and HBV among Afghan refugees

Khanani, M. R., Ansari, A. S., Khan, S., Somani, M., Kazmi, S. U. & Ali, S. H., Nov 1 2010, In : Journal of Infection. 61, 5, p. 434-437 4 p.

Research output: Contribution to journalLetter

15 Citations (Scopus)

Congenital lupus erythematosus affecting both twins

Terzic, M., Kontic-Vucinic, O., Stimec, B., Dokic, M. & Kostic, S., Jul 1 2008, In : Journal of Perinatal Medicine. 36, 4, p. 365-366 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Correspondence: Efavirenz dose reduction in HIV-infected patients: A long-term follow-up

Lanzafamea, M., Lattuadab, E., Cucchettob, G., Conciab, E. & Vento, S., Jan 1 2014, In : AIDS. 28, 18, p. 2789-2790 2 p.

Research output: Contribution to journalLetter

7 Citations (Scopus)

Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes [3]

Cainelli, F., Manzaroli, D., Renzini, C., Casali, F., Concia, E. & Vento, S., Jan 1 2000, In : Diabetes Care. 23, 7, p. 1021-1022 2 p.

Research output: Contribution to journalLetter

Open Access
9 Citations (Scopus)

Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis [7]

Cainelli, F., Concia, E. & Vento, S., Dec 1 2000, In : British Journal of Dermatology. 143, 6, p. 1327-1328 2 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)

CYTOMEGALOVIRUS AND IgA NEPHROPATHY

Jasani, B., Griffiths, D. F. R., Sato, M., Kojima, H., Shinkai, Y. & Koshikawa, S., Nov 26 1988, In : The Lancet. 332, 8622, 1 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: Clinical implications in patients on CD4 T-cell-guided treatment interruption [2]

Lanzafame, M., Lattuada, E., Gottardi, M., Antolini, D., Concia, E. & Vento, S., Jun 1 2007, In : AIDS. 21, 10, p. 1384-1386 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Discordant manifestations of hepatitis c in monozygotic twins

Vento, S., Guella, L. & Concia, E., Nov 2 1995, In : New England Journal of Medicine. 333, 18, p. 1224-1225 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Does tenofovir increase efavirenz hepatotoxicity?

Lattuada, E., Lanzafame, M., Carolo, G., Gottardi, M., Concia, E. & Vento, S., May 1 2008, In : AIDS. 22, 8, 1 p.

Research output: Contribution to journalLetter

7 Citations (Scopus)

Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients

Rizzardo, S., Lanzafame, M., Lattuada, E., Luise, D., Vincenzi, M., Tacconelli, E. & Vento, S., Aug 1 2019, In : AIDS. 33, 10, p. 1673-1674 2 p.

Research output: Contribution to journalLetter

4 Citations (Scopus)

Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life

Lattuada, E., Lanzafame, M., Nicolè, S., Rigo, F., Cucchetto, G., Concia, E. & Vento, S., Feb 1 2018, In : International Journal of STD and AIDS. 29, 2, p. 206-207 2 p.

Research output: Contribution to journalLetter

Dolutegravir monotherapy in HIV-infected naive patients with <100,000 Copies/mL HIV RNA load: To the editors

Lanzafame, M., Gibellini, D., Lattuada, E., Signoretto, C., Mazzi, R., Concia, E. & Vento, S., May 1 2016, In : Journal of Acquired Immune Deficiency Syndromes. 72, 1, p. e12-e14

Research output: Contribution to journalLetter

11 Citations (Scopus)

DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug

Lanzafame, M., Lattuada, E. & Vento, S., Nov 15 2019, In : Clinical Infectious Diseases. 69, 10, 1 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients

Rigo, F., Cucchetto, G., Lanzafame, M., Nicolè, S., Lattuada, E., Concia, E. & Vento, S., Nov 1 2017, In : HIV Medicine. 18, 10, p. 790-792 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Early detection of lung cancer in high-risk patients with HIV-1 infection [5]

Lanzafame, M., Mazzi, R., Faggian, F., Concia, E. & Vento, S., Mar 1 2004, In : International Journal of STD and AIDS. 15, 3, p. 211-212 2 p.

Research output: Contribution to journalLetter

Economic bust-Environment boom?

Fok, S. C., Jun 1 2009, In : Research Journal of Chemistry and Environment. 13, 2, p. 84-85 2 p.

Research output: Contribution to journalLetter

Efavirenz dose reduction in HIV-infected patients

Lanzafame, M., Bonora, S., Lattuada, E. & Vento, S., Apr 1 2012, In : HIV Medicine. 13, 4, p. 252-253 2 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)

Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

Nicolè, S., Lanzafame, M., Lattuada, E., Luise, D., Vecchi, M., Tacconelli, E. & Vento, S., Aug 3 2019, In : Infectious Diseases. 51, 8, p. 615-617 3 p.

Research output: Contribution to journalLetter

Effect of folic acid and B vitamins on cardiovascular disease in women [2]

Akilzhanova, A., Takamura, N. & Yamashita, S., Sep 24 2008, In : JAMA - Journal of the American Medical Association. 300, 12, p. 1409-1410 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced hiv-infected patients: A medium-term follow-up

Lanzafame, M., Lattuada, E., Rigo, F., Ferrari, A., Hill, A. & Vento, S., Feb 1 2015, In : Journal of Antimicrobial Chemotherapy. 70, 2, p. 627-630 4 p.

Research output: Contribution to journalLetter

8 Citations (Scopus)